NYSE:HUMHumana Stock Price, Forecast & News

Humana's stock was trading at $328.22 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, HUM stock has increased by 25.1% and is now trading at $410.65. View which stocks have been most impacted by Coronavirus.

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Humana in the last year. There are currently 5 hold ratings and 13 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Humana.

Humana is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for Humana.

Humana Inc (NYSE:HUM) announced its earnings results on Wednesday, April, 29th. The insurance provider reported $5.40 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $4.84 by $0.56. The insurance provider had revenue of $18.94 billion for the quarter, compared to analyst estimates of $18.49 billion. Humana had a net margin of 3.86% and a return on equity of 21.02%. The company's quarterly revenue was up 17.6% on a year-over-year basis. During the same period in the previous year, the business posted $4.48 EPS. View Humana's earnings history.

Humana declared a quarterly dividend on Thursday, April 23rd. Stockholders of record on Tuesday, June 30th will be given a dividend of $0.625 per share on Friday, July 31st. This represents a $2.50 dividend on an annualized basis and a yield of 0.61%. The ex-dividend date of this dividend is Monday, June 29th. View Humana's dividend history.

Humana issued an update on its FY 2020 Pre-Market earnings guidance on Friday, May, 29th. The company provided earnings per share (EPS) guidance of 18.25-18.75 for the period, compared to the Thomson Reuters consensus estimate of $18.54.

18 Wall Street analysts have issued twelve-month price objectives for Humana's shares. Their forecasts range from $290.00 to $500.00. On average, they expect Humana's share price to reach $405.94 in the next twelve months. This suggests that the stock has a possible downside of 1.1%. View analysts' price targets for Humana.

Headlines about HUM stock have trended very negative this week, according to InfoTrie. InfoTrie ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Humana earned a daily sentiment score of -3.5 on InfoTrie's scale. They also gave headlines about the insurance provider a news buzz of 9.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the immediate future. View the latest news aboutHumana.

Some companies that are related to Humana include UnitedHealth Group (UNH), Cigna (CI), Anthem (ANTM), Centene (CNC), Molina Healthcare (MOH), Magellan Health (MGLN) and Triple-S Management (GTS). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Humana investors own include UnitedHealth Group (UNH), NVIDIA (NVDA), Visa (V), Walt Disney (DIS), Alibaba Group (BABA), Mastercard (MA), Boeing (BA), salesforce.com (CRM), JPMorgan Chase & Co. (JPM) and CVS Health (CVS).

Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."

Humana's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (8.18%), Capital International Investors (6.32%), State Street Corp (4.40%), Capital World Investors (3.63%), Capital Research Global Investors (2.80%) and Wellington Management Group LLP (1.68%). Company insiders that own Humana stock include Brian P Leclaire, Bruce D Broussard, Christopher H Hunter, Cynthia H Zipperle, David A Jr/Ky Jones, Elizabeth D Bierbower, Heidi S Margulis, James J /Ky Obrien, Jody L Bilney, Roy A Beveridge, Timothy Alan Wheatley, Timothy S Huval and William Kevin Fleming. View institutional ownership trends for Humana.

HUM stock was sold by a variety of institutional investors in the last quarter, including Capital Research Global Investors, Capital International Investors, BlackRock Inc., California Public Employees Retirement System, PointState Capital LP, Capital World Investors, Grantham Mayo Van Otterloo & Co. LLC, and Ruffer LLP. Company insiders that have sold Humana company stock in the last year include Brian P Leclaire, David A Jr/Ky Jones, Elizabeth D Bierbower, James J /Ky Obrien, Timothy Alan Wheatley, and Timothy S Huval. View insider buying and selling activity for Humana.

HUM stock was purchased by a variety of institutional investors in the last quarter, including APG Asset Management N.V., Jennison Associates LLC, Lone Pine Capital LLC, Janus Henderson Group PLC, Maverick Capital Ltd., Unigestion Holding SA, AJO LP, and AQR Capital Management LLC. View insider buying and selling activity for Humana.

Shares of HUM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of HUM stock can currently be purchased for approximately $410.65.

Humana has a market capitalization of $54.29 billion and generates $64.89 billion in revenue each year. The insurance provider earns $2.71 billion in net income (profit) each year or $17.87 on an earnings per share basis. Humana employs 46,000 workers across the globe.

The official website for Humana is www.humana.com.

Humana's mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The insurance provider can be reached via phone at 502-580-1000 or via email at [email protected]